Uyttenhove C - Search Results

1

Prophylactic treatment against GM-CSF, but not IL-17, abolishes relapses in a chronic murine model of multiple sclerosis.

Uyttenhove C, Gaignage M, Donckers D, Nasr Z, Cheou P, van Snick J, D'Auria L, van Pesch V. Uyttenhove C, et al. Eur J Immunol. 2018 Nov;48(11):1883-1891. doi: 10.1002/eji.201847580. Epub 2018 Sep 25. Eur J Immunol. 2018. PMID: 30216414 Free article.

2

Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection.

Uyttenhove C, Arendse B, Stroobant V, Brombacher F, Van Snick J. Uyttenhove C, et al. Eur J Immunol. 2004 Dec;34(12):3572-81. doi: 10.1002/eji.200425443. Eur J Immunol. 2004. PMID: 15549728 Free article.

3

Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis.

Uyttenhove C, Van Snick J. Uyttenhove C, et al. Eur J Immunol. 2006 Nov;36(11):2868-74. doi: 10.1002/eji.200636662. Eur J Immunol. 2006. PMID: 17048276 Free article.

4

TGF-β interactions with IL-1 family members trigger IL-4-independent IL-9 production by mouse CD4(+) T cells.

Uyttenhove C, Brombacher F, Van Snick J. Uyttenhove C, et al. Eur J Immunol. 2010 Aug;40(8):2230-5. doi: 10.1002/eji.200940281. Eur J Immunol. 2010. PMID: 20540113 Free article.

5

Novel antibodies that selectively block mouse IL-12 enable the re-evaluation of the role of IL-12 in immune protection and pathology.

Gaignage M, Uyttenhove C, Jones LL, Bourdeaux C, Chéou P, Mandour MF, Coutelier JP, Vignali DAA, Van Snick J. Gaignage M, et al. Among authors: uyttenhove c. Eur J Immunol. 2021 Jun;51(6):1482-1493. doi: 10.1002/eji.202048936. Epub 2021 Apr 9. Eur J Immunol. 2021. PMID: 33788263 Free article.

6

Anti-IL-17A autovaccination prevents clinical and histological manifestations of experimental autoimmune encephalomyelitis.

Uyttenhove C, Sommereyns C, Théate I, Michiels T, Van Snick J. Uyttenhove C, et al. Ann N Y Acad Sci. 2007 Sep;1110:330-6. doi: 10.1196/annals.1423.035. Ann N Y Acad Sci. 2007. PMID: 17911448

7

ICOS deficiency results in exacerbated IL-17 mediated experimental autoimmune encephalomyelitis.

Galicia G, Kasran A, Uyttenhove C, De Swert K, Van Snick J, Ceuppens JL. Galicia G, et al. Among authors: uyttenhove c. J Clin Immunol. 2009 Jul;29(4):426-33. doi: 10.1007/s10875-009-9287-7. Epub 2009 Mar 17. J Clin Immunol. 2009. PMID: 19291374

8

Anti-cytokine auto-vaccinations as tools for the analysis of cytokine function in vivo.

Uyttenhove C, Van Snick J. Uyttenhove C, et al. Cytokine Growth Factor Rev. 2012 Feb-Apr;23(1-2):1-6. doi: 10.1016/j.cytogfr.2011.12.001. Epub 2012 Jan 10. Cytokine Growth Factor Rev. 2012. PMID: 22236653 Review.

9

IL-27p28 is essential for parent-to-F1 acute graft-versus-host disease.

Marillier RG, Uyttenhove C, Goriely S, Marbaix E, Van Snick J. Marillier RG, et al. Among authors: uyttenhove c. Eur J Immunol. 2014 Jul;44(7):2064-73. doi: 10.1002/eji.201444491. Epub 2014 Apr 27. Eur J Immunol. 2014. PMID: 24700119 Free article.

10

Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor.

Vink A, Uyttenhove C, Wauters P, Van Snick J. Vink A, et al. Among authors: uyttenhove c. Eur J Immunol. 1990 Jan;20(1):1-6. doi: 10.1002/eji.1830200102. Eur J Immunol. 1990. PMID: 2407536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters